Esther Choi
About Esther Choi
Esther Choi is the Executive Director at Bristol-Myers Squibb in Brussels, Belgium, with over 30 years of experience in the pharmaceuticals industry.
Company
Esther Choi is currently the Executive Director at Bristol-Myers Squibb, a global biopharmaceutical company. She is based in the Brussels Area, Belgium. Bristol-Myers Squibb specializes in innovative medicines and life-saving therapies, and Esther's role involves overseeing various aspects of drug development and regulatory affairs.
Title
As the Executive Director at Bristol-Myers Squibb, Esther Choi leads efforts in drug development and regulatory compliance. She manages key initiatives aligning with the company’s mission to discover, develop, and deliver innovative medicines that help patients prevail over serious diseases.
Education and Expertise
Esther Choi earned a Doctor of Philosophy (Ph.D.) in Cell Biology and Physiology from the University of California, Santa Barbara, from 1987 to 1992. With over 30 years in the pharmaceutical industry, she specializes in therapeutic areas including immunology, fibrosis, neurobiology, cardiovascular, virology, and oncology. Esther is well-versed in both US and EU regulatory requirements and excels in health authority negotiations.
Background
Esther Choi has a robust background in biotechnology and biologic/drug development, covering early and late development stages as well as life cycle management. She began her career at Amgen Inc. as a Development Scientist, where she worked for nine years from 1991 to 2000 in Thousand Oaks, California. Since March 2001, she has been contributing to Bristol-Myers Squibb's success in various executive capacities.